Call for Abstract
19th World Congress on Infection Prevention and Control, will be organized around the theme “Novel Insights to Explore the Innovatory Strategies in Infection Control and Prevention”
Infection Prevention 2023 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Infection Prevention 2023
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Infection care and management (IPC) may be a scientific approach and sensible answer designed to control the effect caused by infection to patients and medical examiners. One among the foremost necessary routes for transmission of infection is that the hands. Hands that infected with any contaminated item, surface or object may be contaminated with germs from that supply. The contagious transmit might deals with raw food, animals, and spattered nappies, dirty surfaces like bathrooms or hands contaminated/ infected with nasal secretion or spit when reflex, coughing or drooling. Infection hindrance associate degree management. It aims to safeguard those that could be liable to getting an infection, each within the general community and whereas receiving care thanks to health issues. Health care analysis is exposure to blood, saliva, several body fluids or aerosols which will transmit infectious materials like viral hepatatis, HIV, or different blood borne or humour microorganism. It prevents contact with probably infectious diseases by making a physical barrier between the potential infectious materials.
- Track 1-1Enterovirus
- Track 1-2Antimicrobial substances
- Track 1-3Immune mechanisms
- Track 1-4Anti-infective drugs
- Track 1-5Host genetic factors
- Track 1-6Infectious and non-infectious diseases vaccines
- Track 1-7Antibiotic Resistance
- Track 1-8Tx & Immuno compromised
- Track 1-9Severe acute respiratory syndrome
The most number of affected pregnant women is increasing, but scarce information is available about the clinical features Obstetrics Infections outcomes of pregnant patients with COVID-19 in pregnancy caused by severe acute respiratory syndrome coronavirus Moreover maternal, fetal, and neonatal outcomes of patients who were infected in late pregnancy appeared very good, and these outcomes were achieved with intensive, active management that might be the best practice in the absence of more robust data. The clinical characteristics of these patients with COVID-19 during pregnancy were similar to those of non-pregnant adults with COVID-19 clinical symptoms from 33 Infections with or at risk of COVID-19 were mild and outcomes were favourable of the 3 neonates with symptomatic COVID-19, presented with early-onset SARS-CoV-2 infection. Because strict infection control and prevention procedures were implemented during the delivery, it is likely that the sources of SARS-CoV-2 in the clinical findings or investigations suggestive of COVID-19 affected to mothers, and all samples, including amniotic fluid, cord blood, and breast milk, were negative for SARS-CoV-2. The vertical maternal-fetal transmission cannot be ruled out in the current cohort. Therefore, it is crucial to screen pregnant women and implement strict infection control measures, quarantine of infected mothers, and close monitoring of at risk of COVID-19.
- Track 2-1COVID-19 Pregnancy
- Track 2-2Infectious disease transmission
- Track 2-3Vertical coronavirus
Infections can be caused by bacteria, virus, fungi and parasites through direct contact, indirect contact, insect bites and food contamination. Each infectious disease has its own specific signs and symptoms. General signs and symptoms common to a number of infectious diseases include fever, diarrhoea, fatigue and muscle aches.
- Track 3-1Infectious and non-infectious diseases vaccines
- Track 3-2Next generation vaccines
- Track 4-1Infectious and non-infectious diseases vaccines
- Track 4-2Corona virus
- Track 4-3Pneumonia
- Track 4-42019-nCoV
Infection control deals with procedures and activities which bring to prevent or reduce the risk of transmission of infectious diseases. It is mainly works in a clinical setting or working in certain laboratories are at risk of occupational exposure to blood borne pathogens including hepatatis B (Hep B), hepatatis C (Hep C) and human immune deficiency virus (HIV) as well as occupational exposure to a range of microbiological agents. Standard analysis is the work practices needed to achieve a major level of infection control and prevention. The use of common precautions aims to reduce, and to eliminate the adequate risk of transmission of infection, particularly those caused by blood borne viruses. Microorganisms are present on hands (resident flora) or acquired during healthcare activities (transient flora). In Particular hand hygiene is to reduce the number of microorganisms on your hands, particularly transient flora which may present the greater risk for infection transmission.
- Track 5-1Severe acute respiratory syndrome
- Track 5-2Meaningful data analytics in care
- Track 5-3Antibiotic resistance
- Track 5-4Resurgence of old diseases
An infection whose occurrence has increased in the past years or threatens to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance, public health issues and unhygienic conditions.
- Track 6-1Public health and epidemiology
- Track 6-2Microbiome studies
Global market report of infections is a complete study of current trends in the infectious diseases therapeutic and diagnostic market, industry growth drivers, advanced therapies and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology for infection diagnosis and treatment. Market reports also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
- Track 7-1Zoonosis, vector-borne and emerging infections
- Track 7-2Tropical/parasite infections & travel medicine
- Track 7-3Refugees and migrants
Caution is very important within the medical care unit (ICU). "We generally see a lot of infections in this population due to the length of time they may be in a unit. Infections acquired in the hospitals, especially in the intensive care unit (ICU) settings, ranging between 15% and 20%, may further lead to complications in >40% in critically ill patients. The order of incidence may vary in different settings, but the most usual causes are ventilator-associated pneumonia, intravascular catheter-associated bloodstream infection, catheter-associated urinary tract infection, posttraumatic intra-abdominal infection, and surgical site infection. Designated infection control teams should supervise the process and help in collection and compilation of data. Antibiotic Stewardship Recommendations include constituting a team, close coordination between teams, audit, formulary restriction, de-escalation, optimizing dosing, active use of information technology among other measure.
- Track 8-1Immunity
- Track 8-2Mode of transmission
When disease is caused by an organism that is newly identified and not known previously to infect humans or has changed in susceptibility to an anti-infectious drug, it is commonly called an emerging infectious disease, or simply an emerging infection. The RNA viruses that cause seasonal human epidemics of influenza are highly unstable genetically and mutate frequently during replication. Mutation, or genetic drift, results in susceptibility of individuals regardless of their exposure to the viruses before drift, requiring annual antigenic modifications in seasonal influenza vaccines to ensure protection. The short incubation period, and the mild illness caused by the majority of infections, especially among school aged children, result in rapid transmission potential that leads to seasonal influenza epidemics.
- Track 9-1SARS coronavirus
- Track 9-2Hendra virus
- Track 9-3Hepatitis
- Track 9-4Human herpesvirus
- Track 9-5Prion diseases
Epidemiology studies the patterns, causes and effects of health and disease conditions. It is the cornerstone of public health and informs policy decisions and evidence based practice by identifying risk factors for disease and targets for preventive healthcare. Epidemiologists help with study design, data collection, of data, statistical analysis interpretation and dissemination. Epidemology helped to develop methodology used in clinical research, public health studies and to a lesser extent basic research in the biological sciences.
- Track 10-1Emerging diseases
- Track 10-2Identifying and following an outbreak
- Track 10-3Molecular methods for identifying microbes
- Track 10-4Tracking foodborne pathogens
- Track 10-5SARS Coronavirus
Immunization is that the strategy whereby a methodology is involved in immune or proof against a disease, typically by the administration of AN immunogenic. It is one among cost-effective health investments, with verified strategies that build it accessible to even the foremost hard-to-reach and vulnerable populations. Immunizations are often stated as less risky and an appropriate way to become immune to a particular disease than risking a milder form of the disease itself. Other molecules are used for protection further, for example in experimental vaccines against nicotine (NicVAX) or the hormone ghrelin in experiments to create an obesity vaccine. They are necessary for every adult and youngsters therein they will shield themselves from the numerous diseases out there. Immunization not solely protects kids against deadly diseases but jointly helps in developing children's immune systems.
- Track 11-1Immune response to viral infections
- Track 11-2Host-pathogen interaction
- Track 11-3Severe/systemic fungal infections